CIK 0001359931
- Non-accelerated filer
- Smaller reporting company
Protara Therapeutics, Inc.
Sign in to watch- Ticker
- TARA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 204580525
- Phone
- +1 646-844-0337
- Business address
- 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
- Former names
- Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-09 | Braunstein Scott Director | Grant or award · Stock Option (Right to Buy) | +6,676 | 6,676 | ||
| 2020-01-09 | Braunstein Scott Director | Grant or award · Stock Option (Right to Buy) | +15,737 | 15,737 | ||
| 2020-01-09 | GARCEAU ROGER Director | Grant or award · Stock Option (Right to Buy) | +12,399 | 12,399 | ||
| 2020-01-09 | GARCEAU ROGER Director | Grant or award · Stock Option (Right to Buy) | +10,491 | 10,491 | ||
| 2020-01-09 | Solomon Michael Edward Director | Grant or award · Stock Option (Right to Buy) | +9,537 | 9,537 | ||
| 2020-01-09 | Solomon Michael Edward Director | Grant or award · Stock Option (Right to Buy) | +2,861 | 2,861 | ||
| 2020-01-09 | Solomon Michael Edward Director | Grant or award · Stock Option (Right to Buy) | +6,676 | 6,676 | ||
| 2020-01-09 | Solomon Michael Edward Director | Grant or award · Stock Option (Right to Buy) | +10,491 | 10,491 | ||
| 2020-01-09 | Zummo Jacqueline Sr. Vice President, Research | Grant or award | +28,613 | 28,613 | ||
| 2020-01-09 | Zummo Jacqueline Sr. Vice President, Research | Grant or award · Stock Option (Right to Buy) | +19,075 | 19,075 | ||
| 2020-01-09 | Zummo Jacqueline Sr. Vice President, Research | Grant or award · Stock Option (Right to Buy) | +9,537 | 9,537 | ||
| 2020-01-09 | Zummo Jacqueline Sr. Vice President, Research | Grant or award · Stock Option (Right to Buy) | +9,537 | 9,537 | ||
| 2020-01-09 | Casoy Julio Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +38,151 | 38,151 | ||
| 2020-01-09 | Marshall Randall 10% owner | Grant or award | +654,020 | 654,020 | ||
| 2020-01-09 | Shefferman Jesse CEO and President | Grant or award | +790,274 | 790,274 |
Page 17 of 17 · 335 trades